Lupus nephritis associated with complete C1s deficiency efficiently treated with rituximab: a case report.
Bienaimé
Frank
F
Hôpital Necker-Enfants Malades and INSERM U845, Paris, France. frank.bienaime@inserm.fr
Quartier
Pierre
P
Dragon-Durey
Marie-Agnès
MA
Frémeaux-Bacchi
Véronique
V
Bader-Meunier
Brigitte
B
Patey
Natacha
N
Salomon
Rémi
R
Noël
Laure-Hélène
LH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D018389:Codon, Nonsense; D003173:Complement C1s / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D003171:Complement Pathway, Classical / Q000187:drug effects / Q000235:genetics / Q000276:immunology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018389:Codon, Nonsense; D007155:Immunologic Factors; D000069283:Rituximab; D003173:Complement C1s